抗精神病药物维持治疗：是时候重新思考了？
Antipsychotic Maintenance Treatment: Time to Rethink?
作者信息
Moncrieff Joanna
机构信息
Division of Psychiatry, University College London, London, United Kingdom.
出版信息
PLoS Med. 2015 Aug 4;12(8):e1001861. doi: 10.1371/journal.pmed.1001861. eCollection 2015 Aug.
Abstract
Joanna Moncrieff looks at the lack of long-term evidence for antipsychotic medication and considers what is needed to ensure we have the knowledge to maximize benefits and minimize harms.
摘要
乔安娜·蒙克里夫审视了抗精神病药物缺乏长期证据的情况，并思考需要做些什么来确保我们掌握知识，以实现利益最大化和危害最小化。
相似文献
1
Antipsychotic Maintenance Treatment: Time to Rethink?
PLoS Med. 2015 Aug 4;12(8):e1001861. doi: 10.1371/journal.pmed.1001861. eCollection 2015 Aug.
2
Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction).
BMJ Open. 2019 Nov 27;9(11):e030912. doi: 10.1136/bmjopen-2019-030912.
3
Choice of maintenance medication for schizophrenia.
J Clin Psychiatry. 2003;64 Suppl 16:24-33.
4
Intermittent medication--an alternative?
Acta Psychiatr Scand Suppl. 1994;382:33-8. doi: 10.1111/j.1600-0447.1994.tb05863.x.
5
Is there rebound psychosis on withdrawal of antipsychotic medication in schizophrenia?
Schizophr Res. 2018 Nov;201:430-431. doi: 10.1016/j.schres.2018.06.008. Epub 2018 Jun 8.
6
Switch or stay?
Am J Psychiatry. 2006 Dec;163(12):2032-3. doi: 10.1176/ajp.2006.163.12.2032.
7
Treating prodromal episodes to prevent relapse in schizophrenia.
Br J Psychiatry Suppl. 1989 Jul(5):123-7.
8
Oral antipsychotic update: a brief review of new and investigational agents for the treatment of schizophrenia.
CNS Spectr. 2012 Nov;17 Suppl 1:1-9. doi: 10.1017/S1092852912000727.
9
Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention.
Expert Opin Pharmacother. 2010 Oct;11(14):2301-17. doi: 10.1517/14656566.2010.499125.
10
Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.
Clin Ther. 2008 Feb;30(2):231-48. doi: 10.1016/j.clinthera.2008.02.011.
引用本文的文献
1
The Association Between Antipsychotics and Bone Fragility: An Updated Comprehensive Review.
Diagnostics (Basel). 2024 Dec 5;14(23):2745. doi: 10.3390/diagnostics14232745.
2
Verification of successful maintenance by serum drug level during a guided antipsychotic reduction to reach minimum effective dose (GARMED) trial.
Psychol Med. 2024 Sep 26;54(14):1-11. doi: 10.1017/S0033291724002356.
3
The pharmacological treatment of schizophrenia: How far have we come?
PCN Rep. 2022 May 30;1(2):e13. doi: 10.1002/pcn5.13. eCollection 2022 Jun.
4
Combination of Two Long-Acting Antipsychotics in Schizophrenia Spectrum Disorders: A Systematic Review.
Brain Sci. 2024 Apr 26;14(5):433. doi: 10.3390/brainsci14050433.
5
Gradually tapering off antipsychotics: lessons for practice from case studies and neurobiological principles.
Curr Opin Psychiatry. 2024 Jul 1;37(4):320-330. doi: 10.1097/YCO.0000000000000940. Epub 2024 May 9.
6
Collaborative care approaches for people with severe mental illness.
Cochrane Database Syst Rev. 2024 May 7;5(5):CD009531. doi: 10.1002/14651858.CD009531.pub3.
7
Antipsychotic Discontinuation through the Lens of Epistemic Injustice.
Community Ment Health J. 2025 Feb;61(2):244-247. doi: 10.1007/s10597-024-01274-7. Epub 2024 Apr 8.
8
Time-dependent effect of antipsychotic discontinuation and dose reduction on social functioning and subjective quality of life-a multilevel meta-analysis.
EClinicalMedicine. 2023 Nov 9;65:102291. doi: 10.1016/j.eclinm.2023.102291. eCollection 2023 Nov.
9
Addressing the Evidence to Practice Gap: What to Expect From International Antipsychotic Dose Reduction Studies in the Tapering Anti-Psychotics and Evaluating Recovery Consortium.
Schizophr Bull. 2024 Jan 1;50(1):5-8. doi: 10.1093/schbul/sbad112.
10
Investigating the symptomatic and morphological changes in the brain based on pre and post-treatment: A critical review from clinical to neuroimaging studies on schizophrenia.
IBRO Neurosci Rep. 2023 Mar 24;14:366-374. doi: 10.1016/j.ibneur.2023.03.008. eCollection 2023 Jun.
本文引用的文献
1
Tardive dyskinesia and tardive dystonia with second-generation antipsychotics in non-elderly schizophrenic patients unexposed to first-generation antipsychotics: a cross-sectional and retrospective study.
J Clin Psychopharmacol. 2015 Feb;35(1):13-21. doi: 10.1097/JCP.0000000000000250.
2
Tardive dyskinesia in patients treated with atypical antipsychotics: case series and brief review of etiologic and treatment considerations.
Drugs Context. 2014 Apr 9;3:212259. doi: 10.7573/dic.212259. eCollection 2014.
3
Risk of mortality (including sudden cardiac death) and major cardiovascular events in atypical and typical antipsychotic users: a study with the general practice research database.
Cardiovasc Psychiatry Neurol. 2013;2013:247486. doi: 10.1155/2013/247486. Epub 2013 Dec 26.
4
Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial.
JAMA Psychiatry. 2013 Sep;70(9):913-20. doi: 10.1001/jamapsychiatry.2013.19.
5
Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies.
Neurosci Biobehav Rev. 2013 Sep;37(8):1680-91. doi: 10.1016/j.neubiorev.2013.06.001. Epub 2013 Jun 14.
6
The myth of schizophrenia as a progressive brain disease.
Schizophr Bull. 2013 Nov;39(6):1363-72. doi: 10.1093/schbul/sbs135. Epub 2012 Nov 20.
7
Patient online report of selective serotonin reuptake inhibitor-induced persistent postwithdrawal anxiety and mood disorders.
Psychother Psychosom. 2012;81(6):386-8. doi: 10.1159/000341178. Epub 2012 Sep 6.
8
Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis.
Lancet. 2012 Jun 2;379(9831):2063-71. doi: 10.1016/S0140-6736(12)60239-6. Epub 2012 May 3.
9
Treatment response after relapse in a placebo-controlled maintenance trial in schizophrenia.
Schizophr Res. 2012 Jun;138(1):29-34. doi: 10.1016/j.schres.2012.02.030. Epub 2012 Mar 23.
10
Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study.
Psychol Med. 2012 Oct;42(10):2145-55. doi: 10.1017/S0033291712000220. Epub 2012 Feb 17.
Zotero 插件